Trase announced it raised a $107 million seed funding round to continue building its agentic operating system for regulated industries. The round was led by ARCH Venture Partners, with participation from Red Cell Partners and other investors.
Trase is a full-stack AI company providing an agentic operating system and AI agents for high-stakes environments. The company is led by CEO Grant Verstandig and President Baskar Sridharan.
The platform is designed for regulated industries where security, governance, sovereignty, auditability, and predictability are critical. Trase said its system includes hundreds of agents that can be deployed across multiple verticals in weeks rather than months.
Trase’s operating system is built to support compliance and governance across workflows while helping enterprise organizations improve performance and create operational value. The company’s platform can run across cloud, on-premise, or edge environments while providing unified policy enforcement, continuous monitoring, and immutable audit trails.
Since launching last fall, Trase has been working with Duke University Health System to deploy specialized agents within its Division of Cardiology. One use case involves automating the routing of more than 5,000 faxes the clinic receives each month, a task previously handled by trained medical assistants or nurses.
Initial observations from live agents at Duke showed that AI routing completed fax triage 7.1 times faster than manual processing, saved staffers 1,395 hours per month, and unlocked $285,450 in annual staff capacity. Those hours are being reinvested in patient care rather than headcount reduction.
Trase said the fax routing agent is part of a broader ecosystem of agents deployed or ready to be deployed at Duke. These agents are designed to reduce time-consuming administrative workflows and support areas such as chronic condition management.
All Trase agents are designed to run reliably in high-stakes environments, with data sovereignty, reinforcement learning from human feedback, auditability, and a judgment layer that determines which decisions should be handled by a human.
Trase plans to use the funding to expand its go-to-market team and continue developing Trase Origin, the company’s operating system. The company has grown to 55 team members across the U.S., with hubs in Seattle and the Washington, D.C. metro area.
Trase is HIPAA- and SOC 2-compliant and focused on enabling organizations to deploy trustworthy, predictable AI agents across mission-critical workflows.
KEY QUOTES:
“Regulated industries are full of brilliant people who can exponentially serve their country and their customers through the power of AI. Trase delivers that boost to augment capabilities. Grant has built the right team, the right technology, and has proven it works in industries that are the most demanding for performance.”
Robert Nelsen, Co-Founder and Managing Director of ARCH Venture Partners
“We used to show up on Monday mornings to hundreds of faxes waiting to be routed. When we first turned on the Trase fax routing agent, it processed the lion’s share of them by the end of the day. It liberated our team to focus on the work they actually trained for and enjoy doing. This work with Trase has shown us that the promise of AI in a clinical setting is real.”
Manesh Patel, MD, Chief of the Division of Cardiology at Duke Health
“We’re honored to welcome Bob Nelsen and ARCH to the team. In the age of AI, powered by the sovereignty, predictability, and trustworthiness that Trase’s OS delivers, agents are handling the onerous, immutable tasks that bog down highly trained individuals. Shifting that valuable mental capacity to higher-acuity work will help make the most important systems in the United States cheaper, faster, and better for every American.”
Grant Verstandig, CEO and Co-Founder of Trase
